Trial Profile
Retrospective study of infliximab, adalimumab, etanercept and ustekinumab in patients with plaque psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 30 Aug 2018 New trial record